Filter posts

“Please Wait a Few Moments While Your Pill Prints”

Since the late 1980’s, innovators have dreamed of living in a world where science could …

Congress, Media Focused on Biotech Food Labeling

Media coverage of the biotech food labeling debate is at a fever pitch as the …

FDA Acts on Biosimilars

The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …

Expanding the Role of Patients in Drug Development

Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to …

BIO Is Almost Here – What To Consider Before Entering New Therapeutic Areas

Over the past decade, the biopharmaceutical industry has witnessed a shift towards specialty care. From …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

The Administration Focuses on Improving Food Safety

The Obama administration wants to establish a new agency that would be housed within the Department of …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

Survey Shows Americans Support Labeling Foods Containing DNA

A recent survey by the Oklahoma State University Department of Agricultural Economics finds that over 80 percent …